Company intelligence / Profile preview

Cormay Diagnostics

Ownership: Private
Development stage: Commercial

Overview

Cormay Diagnostics develops and manufactures innovative in-vitro diagnostic solutions—including reagents and analyzers—used for early detection, treatment guidance, and monitoring of patient health. Their products are distributed in over 120 countries with more than 20,000 analyzers sold worldwide. The company focuses on providing affordable high-quality technology to small and mid-size clinical laboratories.

Therapeutic areas: Other
Modalities: DeviceDiagnostic reagentIn-vitro diagnostic solution
Industry: Metabolite Diagnostics

Partnerships

Randox Laboratories Ltd. ("Joins Forces" for external quality control/RQIAs program)

Beyond the preview

Go deeper on Cormay Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cormay Diagnostics.

Explore the full profile